Successful Annual Meeting in Prague

The second RADAR-CNS Annual Meeting took place in Prague, Czech Republic, from 17 to 19 April 2018. Members of the project’s Patient Advisory Board, Scientific Advisory Board and more than eighty clinicians, researchers, engineers, computer scientists and bioinformaticians from across the RADAR-...

The three-day programme combined updates from across the project teams, including an overview of the new RADAR-BASE platform, and detailed discussion of study protocol (Dr Marta Radaelli pictured) and recruitment procedures.  

There was also the first Young Investigators meeting where people at the start of their careers came together to discuss experiences and compare notes.  

The conference delegates heard from two key note speakers:

Robert Neusner, global commercial strategy director at Neuroscience Diagnostics, a division of Janssen Pharmaceutica, discussed RMT in practice: Bridging the gap from research to real world adoption. Bob is a special advisor to the consortium. He began by exploring the exciting potential for modern-day RMT in health monitoring and treatment decision-making, before outlining some 'key design decisions' to consider during product development. Bob concluded by providing some invaluable advice on crossing the gap between research and adoption into the health care system.

Dr Tom Insel, co-founder and President of Mindstrong Health, and a member of the RADAR-CNS Scientific Advisory Board, outlined how he thought technology will transform mental healthcare. Tom discussed ways in which data collected via digital technologies could be used to measure mood, cognition and behaviour. A phone’s keyboard, for example, can tell us a lot about attention processing speed. Phone sensors recording light, location or speech are other examples of means of recording ‘digital phenotypes’ of mental health disorders.  According to Tom, these can help to measure symptoms continuously and in an objective way, empowering patients with richer information and allowing proactive action. Importantly, he emphasised that digital healthcare would require a serious take on data privacy as well as transparency regarding the data being collected.

Aki Rintala, a PhD student at KU Leuven, received the best poster pitch award for his three minute presentation on ‘Compliance in studies using the experience sampling method (ESM)’. He was one of five people to present a poster pitch to highlight the research emerging from the consortium.

At the meeting’s close, co-leads Dr Vaibhav Narayan, Janssen Pharmacetutica, and Professor Matthew Hotopf, King’s College London, thanked the Patient Advisory Board, Scientific Advisory Board and consortium members for their contributions and input, insight and collaboration.